MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Clinical trials for MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can adding another drug improve MDS treatment?
Disease control OngoingThis study compares the standard drug azacitidine alone versus azacitidine combined with either lenalidomide or vorinostat in 282 patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to see if any combination improves re…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental Triple-Drug cocktail targets Hard-to-Treat leukemia
Disease control TerminatedThis early-phase trial tests whether adding regorafenib to the standard venetoclax and azacitidine regimen is safe and effective for people with acute myeloid leukemia (AML) that has returned or not responded to prior treatment. About 20 adults will receive the three-drug combina…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC